Loading…

Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy

Abstract Background and purpose Evaluating chronic sequelae of optic neuritis, such as optic neuropathy with or without optic nerve atrophy, can be challenging on whole brain MRI. This study evaluated the utility of dedicated coronal contrast-enhanced fat-suppressed FLAIR (CE-FS-FLAIR) MR imaging to...

Full description

Saved in:
Bibliographic Details
Published in:European journal of radiology Open 2017-01, Vol.4, p.13-18
Main Authors: Boegel, Kevin H, Tyan, Andrew E, Iyer, Veena R, Rykken, Jeffrey B, McKinney, Alexander M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c576t-4dbec96f94e54bbd6fc3e189cc4baa9846cca6ab45b3a6529d65937c9f758fab3
cites cdi_FETCH-LOGICAL-c576t-4dbec96f94e54bbd6fc3e189cc4baa9846cca6ab45b3a6529d65937c9f758fab3
container_end_page 18
container_issue
container_start_page 13
container_title European journal of radiology Open
container_volume 4
creator Boegel, Kevin H
Tyan, Andrew E
Iyer, Veena R
Rykken, Jeffrey B
McKinney, Alexander M
description Abstract Background and purpose Evaluating chronic sequelae of optic neuritis, such as optic neuropathy with or without optic nerve atrophy, can be challenging on whole brain MRI. This study evaluated the utility of dedicated coronal contrast-enhanced fat-suppressed FLAIR (CE-FS-FLAIR) MR imaging to detect optic neuropathy and optic nerve atrophy. Materials and methods Over 4.5 years, a 3 mm coronal CE-FS-FLAIR sequence at 1.5T was added to the routine brain MRIs of 124 consecutive patients, 102 of whom had suspected or known demyelinating disease. Retrospective record reviews confirmed that 28 of these 102 had documented onset of optic neuritis >4 weeks prior to the brain MRI. These 28 were compared to the other 22 (“controls”) of the 124 patients who lacked a history of demyelinating disease or visual symptoms. Using coronal CE-FS-FLAIR, two neuroradiologists separately graded each optic nerve (n = 50 patients, 100 total nerves) as either negative, equivocal, or positive for optic neuropathy or atrophy. The scoring was later repeated. Results The mean time from acute optic neuritis onset to MRI was 4.1 ± 4.6 years (range 34 days-17.4 years). Per individual nerve grading, the range of sensitivity, specificity, and accuracy of coronal CE-FS-FLAIR in detecting optic neuropathy was 71.4–77.1%, 93.8–95.4%, and 85.5–89.0%, respectively, with strong interobserver (k = 0.667 − 0.678, p < 0.0001), and intraobserver (k = 0.706 − 0.763, p < 0.0001) agreement. For optic atrophy, interobserver agreement was moderate (k = 0.437 − 0.484, p < 0.0001), while intraobserver agreement was moderate-strong (k = 0.491 − 0.596, p < 0.0001). Conclusion Coronal CE-FS-FLAIR is quite specific in detecting optic neuropathy years after the onset of acute optic neuritis, but is less useful in detecting optic nerve atrophy.
doi_str_mv 10.1016/j.ejro.2017.02.002
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4ac8ea35156e4978bf49fa125f480d13</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S2352047717300060</els_id><doaj_id>oai_doaj_org_article_4ac8ea35156e4978bf49fa125f480d13</doaj_id><sourcerecordid>1876490738</sourcerecordid><originalsourceid>FETCH-LOGICAL-c576t-4dbec96f94e54bbd6fc3e189cc4baa9846cca6ab45b3a6529d65937c9f758fab3</originalsourceid><addsrcrecordid>eNp9Uk1v1DAUjBCIVqV_gAPKkcsu_nYioUpV1cJKKyEBPVsvzkvXaRoH21lp_z0OW6qWA6fnj5nx85spiveUrCmh6lO_xj74NSNUrwlbE8JeFaeMS7YiQuvXz9YnxXmMPSGZJYVi5G1xwiqmpZL6tLi_TW5w6VD6rrQ--BGGXMcUIKYVjjsYLbZlB2kV52kKGGPe3mwvN99LN5ZphyXuYZghOT8uGn5KzpYjzsFPkHaHEsa2hJR3u8O74k0HQ8Tzx3pW3N5c_7z6utp--7K5utyurNQqrUTboK1VVwuUomla1VmOtKqtFQ1AXQllLShohGw4KMnqVsmaa1t3WlYdNPys2Bx1Ww-9mYJ7gHAwHpz5c-DDnYGQ2xzQCLAVApdUKhS1rppO1B1QJjtRkZbyrHVx1Jrm5gFbi8tohheiL29GtzN3fm8k55SKReDjo0Dwv2aMyTy4aHEYYEQ_R0MrrURNNK8ylB2hNvgYA3ZPz1BiFtNNbxbTzWK6Icxk0zPpw_MGnyh_Lc6Az0cA5pHvHQYTrcPFVhfQpjwT93_9i3_odnCjszDc4wFj7-eQM5P_YWImmB9L7JbUUc1z5BThvwFVBNVa</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1876490738</pqid></control><display><type>article</type><title>Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy</title><source>Elsevier ScienceDirect Journals</source><source>PubMed Central</source><creator>Boegel, Kevin H ; Tyan, Andrew E ; Iyer, Veena R ; Rykken, Jeffrey B ; McKinney, Alexander M</creator><creatorcontrib>Boegel, Kevin H ; Tyan, Andrew E ; Iyer, Veena R ; Rykken, Jeffrey B ; McKinney, Alexander M</creatorcontrib><description>Abstract Background and purpose Evaluating chronic sequelae of optic neuritis, such as optic neuropathy with or without optic nerve atrophy, can be challenging on whole brain MRI. This study evaluated the utility of dedicated coronal contrast-enhanced fat-suppressed FLAIR (CE-FS-FLAIR) MR imaging to detect optic neuropathy and optic nerve atrophy. Materials and methods Over 4.5 years, a 3 mm coronal CE-FS-FLAIR sequence at 1.5T was added to the routine brain MRIs of 124 consecutive patients, 102 of whom had suspected or known demyelinating disease. Retrospective record reviews confirmed that 28 of these 102 had documented onset of optic neuritis &gt;4 weeks prior to the brain MRI. These 28 were compared to the other 22 (“controls”) of the 124 patients who lacked a history of demyelinating disease or visual symptoms. Using coronal CE-FS-FLAIR, two neuroradiologists separately graded each optic nerve (n = 50 patients, 100 total nerves) as either negative, equivocal, or positive for optic neuropathy or atrophy. The scoring was later repeated. Results The mean time from acute optic neuritis onset to MRI was 4.1 ± 4.6 years (range 34 days-17.4 years). Per individual nerve grading, the range of sensitivity, specificity, and accuracy of coronal CE-FS-FLAIR in detecting optic neuropathy was 71.4–77.1%, 93.8–95.4%, and 85.5–89.0%, respectively, with strong interobserver (k = 0.667 − 0.678, p &lt; 0.0001), and intraobserver (k = 0.706 − 0.763, p &lt; 0.0001) agreement. For optic atrophy, interobserver agreement was moderate (k = 0.437 − 0.484, p &lt; 0.0001), while intraobserver agreement was moderate-strong (k = 0.491 − 0.596, p &lt; 0.0001). Conclusion Coronal CE-FS-FLAIR is quite specific in detecting optic neuropathy years after the onset of acute optic neuritis, but is less useful in detecting optic nerve atrophy.</description><identifier>ISSN: 2352-0477</identifier><identifier>EISSN: 2352-0477</identifier><identifier>DOI: 10.1016/j.ejro.2017.02.002</identifier><identifier>PMID: 28275657</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Contrast-enhanced fat-suppressed FLAIR ; Multiple sclerosis ; Optic neuritis ; Optic neuropathy ; Pptic nerve atrophy ; Radiology</subject><ispartof>European journal of radiology Open, 2017-01, Vol.4, p.13-18</ispartof><rights>The Authors</rights><rights>2017 The Authors</rights><rights>2017 The Authors 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c576t-4dbec96f94e54bbd6fc3e189cc4baa9846cca6ab45b3a6529d65937c9f758fab3</citedby><cites>FETCH-LOGICAL-c576t-4dbec96f94e54bbd6fc3e189cc4baa9846cca6ab45b3a6529d65937c9f758fab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331143/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2352047717300060$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3549,27924,27925,45780,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28275657$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boegel, Kevin H</creatorcontrib><creatorcontrib>Tyan, Andrew E</creatorcontrib><creatorcontrib>Iyer, Veena R</creatorcontrib><creatorcontrib>Rykken, Jeffrey B</creatorcontrib><creatorcontrib>McKinney, Alexander M</creatorcontrib><title>Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy</title><title>European journal of radiology Open</title><addtitle>Eur J Radiol Open</addtitle><description>Abstract Background and purpose Evaluating chronic sequelae of optic neuritis, such as optic neuropathy with or without optic nerve atrophy, can be challenging on whole brain MRI. This study evaluated the utility of dedicated coronal contrast-enhanced fat-suppressed FLAIR (CE-FS-FLAIR) MR imaging to detect optic neuropathy and optic nerve atrophy. Materials and methods Over 4.5 years, a 3 mm coronal CE-FS-FLAIR sequence at 1.5T was added to the routine brain MRIs of 124 consecutive patients, 102 of whom had suspected or known demyelinating disease. Retrospective record reviews confirmed that 28 of these 102 had documented onset of optic neuritis &gt;4 weeks prior to the brain MRI. These 28 were compared to the other 22 (“controls”) of the 124 patients who lacked a history of demyelinating disease or visual symptoms. Using coronal CE-FS-FLAIR, two neuroradiologists separately graded each optic nerve (n = 50 patients, 100 total nerves) as either negative, equivocal, or positive for optic neuropathy or atrophy. The scoring was later repeated. Results The mean time from acute optic neuritis onset to MRI was 4.1 ± 4.6 years (range 34 days-17.4 years). Per individual nerve grading, the range of sensitivity, specificity, and accuracy of coronal CE-FS-FLAIR in detecting optic neuropathy was 71.4–77.1%, 93.8–95.4%, and 85.5–89.0%, respectively, with strong interobserver (k = 0.667 − 0.678, p &lt; 0.0001), and intraobserver (k = 0.706 − 0.763, p &lt; 0.0001) agreement. For optic atrophy, interobserver agreement was moderate (k = 0.437 − 0.484, p &lt; 0.0001), while intraobserver agreement was moderate-strong (k = 0.491 − 0.596, p &lt; 0.0001). Conclusion Coronal CE-FS-FLAIR is quite specific in detecting optic neuropathy years after the onset of acute optic neuritis, but is less useful in detecting optic nerve atrophy.</description><subject>Contrast-enhanced fat-suppressed FLAIR</subject><subject>Multiple sclerosis</subject><subject>Optic neuritis</subject><subject>Optic neuropathy</subject><subject>Pptic nerve atrophy</subject><subject>Radiology</subject><issn>2352-0477</issn><issn>2352-0477</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9Uk1v1DAUjBCIVqV_gAPKkcsu_nYioUpV1cJKKyEBPVsvzkvXaRoH21lp_z0OW6qWA6fnj5nx85spiveUrCmh6lO_xj74NSNUrwlbE8JeFaeMS7YiQuvXz9YnxXmMPSGZJYVi5G1xwiqmpZL6tLi_TW5w6VD6rrQ--BGGXMcUIKYVjjsYLbZlB2kV52kKGGPe3mwvN99LN5ZphyXuYZghOT8uGn5KzpYjzsFPkHaHEsa2hJR3u8O74k0HQ8Tzx3pW3N5c_7z6utp--7K5utyurNQqrUTboK1VVwuUomla1VmOtKqtFQ1AXQllLShohGw4KMnqVsmaa1t3WlYdNPys2Bx1Ww-9mYJ7gHAwHpz5c-DDnYGQ2xzQCLAVApdUKhS1rppO1B1QJjtRkZbyrHVx1Jrm5gFbi8tohheiL29GtzN3fm8k55SKReDjo0Dwv2aMyTy4aHEYYEQ_R0MrrURNNK8ylB2hNvgYA3ZPz1BiFtNNbxbTzWK6Icxk0zPpw_MGnyh_Lc6Az0cA5pHvHQYTrcPFVhfQpjwT93_9i3_odnCjszDc4wFj7-eQM5P_YWImmB9L7JbUUc1z5BThvwFVBNVa</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Boegel, Kevin H</creator><creator>Tyan, Andrew E</creator><creator>Iyer, Veena R</creator><creator>Rykken, Jeffrey B</creator><creator>McKinney, Alexander M</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170101</creationdate><title>Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy</title><author>Boegel, Kevin H ; Tyan, Andrew E ; Iyer, Veena R ; Rykken, Jeffrey B ; McKinney, Alexander M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c576t-4dbec96f94e54bbd6fc3e189cc4baa9846cca6ab45b3a6529d65937c9f758fab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Contrast-enhanced fat-suppressed FLAIR</topic><topic>Multiple sclerosis</topic><topic>Optic neuritis</topic><topic>Optic neuropathy</topic><topic>Pptic nerve atrophy</topic><topic>Radiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boegel, Kevin H</creatorcontrib><creatorcontrib>Tyan, Andrew E</creatorcontrib><creatorcontrib>Iyer, Veena R</creatorcontrib><creatorcontrib>Rykken, Jeffrey B</creatorcontrib><creatorcontrib>McKinney, Alexander M</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>European journal of radiology Open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boegel, Kevin H</au><au>Tyan, Andrew E</au><au>Iyer, Veena R</au><au>Rykken, Jeffrey B</au><au>McKinney, Alexander M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy</atitle><jtitle>European journal of radiology Open</jtitle><addtitle>Eur J Radiol Open</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>4</volume><spage>13</spage><epage>18</epage><pages>13-18</pages><issn>2352-0477</issn><eissn>2352-0477</eissn><abstract>Abstract Background and purpose Evaluating chronic sequelae of optic neuritis, such as optic neuropathy with or without optic nerve atrophy, can be challenging on whole brain MRI. This study evaluated the utility of dedicated coronal contrast-enhanced fat-suppressed FLAIR (CE-FS-FLAIR) MR imaging to detect optic neuropathy and optic nerve atrophy. Materials and methods Over 4.5 years, a 3 mm coronal CE-FS-FLAIR sequence at 1.5T was added to the routine brain MRIs of 124 consecutive patients, 102 of whom had suspected or known demyelinating disease. Retrospective record reviews confirmed that 28 of these 102 had documented onset of optic neuritis &gt;4 weeks prior to the brain MRI. These 28 were compared to the other 22 (“controls”) of the 124 patients who lacked a history of demyelinating disease or visual symptoms. Using coronal CE-FS-FLAIR, two neuroradiologists separately graded each optic nerve (n = 50 patients, 100 total nerves) as either negative, equivocal, or positive for optic neuropathy or atrophy. The scoring was later repeated. Results The mean time from acute optic neuritis onset to MRI was 4.1 ± 4.6 years (range 34 days-17.4 years). Per individual nerve grading, the range of sensitivity, specificity, and accuracy of coronal CE-FS-FLAIR in detecting optic neuropathy was 71.4–77.1%, 93.8–95.4%, and 85.5–89.0%, respectively, with strong interobserver (k = 0.667 − 0.678, p &lt; 0.0001), and intraobserver (k = 0.706 − 0.763, p &lt; 0.0001) agreement. For optic atrophy, interobserver agreement was moderate (k = 0.437 − 0.484, p &lt; 0.0001), while intraobserver agreement was moderate-strong (k = 0.491 − 0.596, p &lt; 0.0001). Conclusion Coronal CE-FS-FLAIR is quite specific in detecting optic neuropathy years after the onset of acute optic neuritis, but is less useful in detecting optic nerve atrophy.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>28275657</pmid><doi>10.1016/j.ejro.2017.02.002</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2352-0477
ispartof European journal of radiology Open, 2017-01, Vol.4, p.13-18
issn 2352-0477
2352-0477
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4ac8ea35156e4978bf49fa125f480d13
source Elsevier ScienceDirect Journals; PubMed Central
subjects Contrast-enhanced fat-suppressed FLAIR
Multiple sclerosis
Optic neuritis
Optic neuropathy
Pptic nerve atrophy
Radiology
title Utility of coronal contrast-enhanced fat-suppressed FLAIR in the evaluation of optic neuropathy and atrophy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A00%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20of%20coronal%20contrast-enhanced%20fat-suppressed%20FLAIR%20in%20the%20evaluation%20of%20optic%20neuropathy%20and%20atrophy&rft.jtitle=European%20journal%20of%20radiology%20Open&rft.au=Boegel,%20Kevin%20H&rft.date=2017-01-01&rft.volume=4&rft.spage=13&rft.epage=18&rft.pages=13-18&rft.issn=2352-0477&rft.eissn=2352-0477&rft_id=info:doi/10.1016/j.ejro.2017.02.002&rft_dat=%3Cproquest_doaj_%3E1876490738%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c576t-4dbec96f94e54bbd6fc3e189cc4baa9846cca6ab45b3a6529d65937c9f758fab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1876490738&rft_id=info:pmid/28275657&rfr_iscdi=true